Navigation Links
New push for public health, AIDS spending at African Union summit

Activists hope this weekend's African Union (AU) summit will net commitments to boost government spending on public health, helping to curb the spread of AIDS, which killed 2.3 million Africans in 2004.

"We are definitely optimistic that this time there will be some movement, that this time there will be not just talk about an HIV strategy for the AU but how to tackle an action-oriented plan," Oxfam spokeswoman Shehnilla Mohamed said.

"Governments are learning that fighting AIDS is not just a health issue but a development issue," she said.


"Now they have to deliver on the existing protocols and develop a serious and practical strategy."

Mozambique is the only country that has, thus far, committed to allocating 15 per cent of its gross domestic product to healthcare in the four years since the goal was stated during the founding of the pan-African body.

The rest of the 52 countries included in the African Union spend less than 10 per cent of their annual revenues on health, anti-AIDS and anti-HIV efforts included.

Controversial drug trials, battles over patents and the fate of millions of orphans are also likely to be discussed at a summit session devoted to the fight against AIDS on the world's poorest continent, home to nearly two-thirds of the 39.4 million people worldwide infected with HIV or AIDS.

The World Health Organisation (WHO) says just 310,000 people in Africa were being treated with a cocktail of antiretroviral (ARV) drugs that inhibit the progression of their disease, which has no known cure.

But demand for free drugs vastly outstrips their supply, the cost of the drugs - at some $US600 annually for the rest of a patient's life, an impossible dream on the continent.

Generic versions of the drugs have been priced at roughly $US300 a year, the costs for which the WHO hopes will be offset by national resources, international agencies and private or government donations.

Efforts to provide low-cost drugs to African HIV sufferers received a major boost this month when the US Food and Drug Administration approved the first ARV cocktail, which could open the taps on the promised $US15 billion that President George W Bush promised two years ago for the fight against AIDS.


'"/>

Source:ABC News


Related biology news :

1. Wiley announces publication of Databasing the Brain
2. BioMed Central welcomes the new National Institutes of Health public access policy
3. Not-for-profit publishers call NIH public access rule a missed opportunity
4. CoPub Mapper: mining MEDLINE based on search term co-publication
5. DOE JGI launches IMG public online microbial genome data clearinghouse
6. Understanding biases in epidemic models important when making public health predictions
7. Does manganese inhaled from the shower represent a public health threat?
8. Center releases new public survey on stem cells
9. HIV-infected adults in Botswana respond positively to ARV therapy public treatment program
10. Scientists fetch useful information from dog genome publications
11. Study suggests that publicly available genome data may contain small but significant errors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... YORK , Feb. 7, 2017 ... Driven largely by the confluence of organizations, desires ... distaste for knowledge-based systems (password and challenge questions), ... industrial, and government systems. The market is driven ... a demarcation between consumer and enterprise uses cases, ...
(Date:2/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the LEERINK Partners 6th Annual Global Healthcare Conference ... February 15, 2017 at 10 a.m. Eastern Time. ... be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/3/2017)... Biomedical Research Institute announced that its Board of Trustees has ... Institute,s new President and CEO. Dr. Schlesinger will take the ... currently the Chair of the Department of Microbial Infection and ... at Ohio State University. "We are delighted to ... Texas Biomed," said Dr. James O. Rubin , Board ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ("OncoSec") ... will host a Key Opinion Leader event to highlight ... oral and poster presentation at the upcoming 2017 ASCO-SITC ... KOL event will be held in-person and via live ... / 9:00 AM PST at the Lotte New York ...
(Date:2/23/2017)... 2017 /PRNewswire/ - The Fight Against Cancer Innovation Trust ... are pleased to report that Fusion Pharmaceuticals Inc. (Fusion) ... & Johnson Innovation – JJDC, Inc. (JJDC) as the ... TPG Biotechnology Partners, and Genesys Capital, as well as ... ...
(Date:2/23/2017)... Feb. 23, 2017  Imanis Life Sciences announced ... of oncolytic vaccinia viruses for virotherapy research. These ... of Genelux,s proprietary, vaccinia virus-based technology platform for ... enter into a partnership with Genelux to offer ... viruses for use in research," said Dr. ...
Breaking Biology Technology: